Her goals are to make Piramal Pharma a $2 billion company by 2030 while achieving a 25 per cent EBITDA margin—an aim that ...

With the investment led by Fulgur Ventures and Framework, the firm plans to scale its bitcoin-denominated life insurance and ...

By leveraging its innovative ‘High Tech + High Touch’ strategy alongside ICICI Bank’s banking expertise, Piramal Finance ...

Piramal Finance Limited (formerly known as Piramal Capital & Housing Finance Ltd.), a leading Non-Banking Financial Company ...

And what it wants? To double its AUM in the next five years through cross-selling and a continued semi-urban and rural focus.

GIFT Nifty was trading down 0.89% to 22,398, which indicates a negative start for domestic indices. Here are the top stocks ...

RBI MPC is set to announce key policy decisions today and market participants are expected to follow the announcements made ...

Piramal Finance and ICICI Bank have entered a co-lending partnership to expand access to credit in semi-urban and rural areas.

Piramal Capital & Housing Finance has received approval from the RBI to commence operations as a NBFC-ICC. With this, it will ...

Goldman Sachs has given a target price of Rs 1,350 per share for Suven Pharma and Rs 275 per share for Piramal Pharma.

Piramal Enterprises shares gained attention on April 7 after the RBI allowed its subsidiary Piramal Finance to operate as a ...

At the time of writing this report, shares of Piramal Enterprises, the parent company, were trading over 4% lower at ₹920.05 ...